Conformational heterogeneity of MHC class II induced upon binding to different peptides is a key regulator in antigen presentation and epitope selection

Scheheraza Sadegh-Nasseri, Sateesh Natarajan, Chih Ling Chou, Isamu Z. Hartman, Kedar Narayan, Aeryon Kim

Research output: Contribution to journalArticle

Abstract

T cells bearing αβ receptors recognize antigenic peptides bound to class I and class II glycoproteins encoded in the major histocompatibility complex (MHC). Cytotoxic and helper T cells respond respectively to peptide antigens derived from endogenous sources presented by MHC class I, and exogenous sources presented by MHC II, on antigen presenting cells. Differences in the MHC class I and class II structures and their maturation pathways have evolved to optimize antigen presentation to their respective T cells. A main focus of our laboratory is on efforts to understand molecular events in processing of antigen for presentation by MHC class II. The different stages of MHC class II-interactions with molecular chaperons involved in folding and traffic from the ER through the antigen-loading compartments, peptide exchange, and transport to the cell surface have been investigated. Through intense research on biophysical and biochemical properties of MHC class II molecules, we have learned that the conformational heterogeneity of MHC class II induced upon binding to different peptides is a key regulator in antigen presentation and epitope selection, and a determinant of the ability of MHC class II to participate in peptide association or dissociation and interaction with the peptide editor HLA-DM.

Original languageEnglish (US)
Pages (from-to)56-64
Number of pages9
JournalImmunologic Research
Volume47
Issue number1-3
DOIs
StatePublished - Jul 2010

Fingerprint

Antigen Presentation
Major Histocompatibility Complex
Epitopes
Peptides
Antigens
Molecular Chaperones
Antigen-Presenting Cells
Helper-Inducer T-Lymphocytes
T-Cell Antigen Receptor
Glycoproteins
T-Lymphocytes

Keywords

  • Conformational heterogeneity
  • H-bonds
  • Immunodominance
  • Kinetics
  • MHC class II
  • Peptide-receptive conformation

ASJC Scopus subject areas

  • Immunology
  • Medicine(all)

Cite this

Conformational heterogeneity of MHC class II induced upon binding to different peptides is a key regulator in antigen presentation and epitope selection. / Sadegh-Nasseri, Scheheraza; Natarajan, Sateesh; Chou, Chih Ling; Hartman, Isamu Z.; Narayan, Kedar; Kim, Aeryon.

In: Immunologic Research, Vol. 47, No. 1-3, 07.2010, p. 56-64.

Research output: Contribution to journalArticle

Sadegh-Nasseri, Scheheraza ; Natarajan, Sateesh ; Chou, Chih Ling ; Hartman, Isamu Z. ; Narayan, Kedar ; Kim, Aeryon. / Conformational heterogeneity of MHC class II induced upon binding to different peptides is a key regulator in antigen presentation and epitope selection. In: Immunologic Research. 2010 ; Vol. 47, No. 1-3. pp. 56-64.
@article{9efeb5faf0bf4332b492f1f6908083bc,
title = "Conformational heterogeneity of MHC class II induced upon binding to different peptides is a key regulator in antigen presentation and epitope selection",
abstract = "T cells bearing αβ receptors recognize antigenic peptides bound to class I and class II glycoproteins encoded in the major histocompatibility complex (MHC). Cytotoxic and helper T cells respond respectively to peptide antigens derived from endogenous sources presented by MHC class I, and exogenous sources presented by MHC II, on antigen presenting cells. Differences in the MHC class I and class II structures and their maturation pathways have evolved to optimize antigen presentation to their respective T cells. A main focus of our laboratory is on efforts to understand molecular events in processing of antigen for presentation by MHC class II. The different stages of MHC class II-interactions with molecular chaperons involved in folding and traffic from the ER through the antigen-loading compartments, peptide exchange, and transport to the cell surface have been investigated. Through intense research on biophysical and biochemical properties of MHC class II molecules, we have learned that the conformational heterogeneity of MHC class II induced upon binding to different peptides is a key regulator in antigen presentation and epitope selection, and a determinant of the ability of MHC class II to participate in peptide association or dissociation and interaction with the peptide editor HLA-DM.",
keywords = "Conformational heterogeneity, H-bonds, Immunodominance, Kinetics, MHC class II, Peptide-receptive conformation",
author = "Scheheraza Sadegh-Nasseri and Sateesh Natarajan and Chou, {Chih Ling} and Hartman, {Isamu Z.} and Kedar Narayan and Aeryon Kim",
year = "2010",
month = "7",
doi = "10.1007/s12026-009-8138-1",
language = "English (US)",
volume = "47",
pages = "56--64",
journal = "Immunologic Research",
issn = "0257-277X",
publisher = "Humana Press",
number = "1-3",

}

TY - JOUR

T1 - Conformational heterogeneity of MHC class II induced upon binding to different peptides is a key regulator in antigen presentation and epitope selection

AU - Sadegh-Nasseri, Scheheraza

AU - Natarajan, Sateesh

AU - Chou, Chih Ling

AU - Hartman, Isamu Z.

AU - Narayan, Kedar

AU - Kim, Aeryon

PY - 2010/7

Y1 - 2010/7

N2 - T cells bearing αβ receptors recognize antigenic peptides bound to class I and class II glycoproteins encoded in the major histocompatibility complex (MHC). Cytotoxic and helper T cells respond respectively to peptide antigens derived from endogenous sources presented by MHC class I, and exogenous sources presented by MHC II, on antigen presenting cells. Differences in the MHC class I and class II structures and their maturation pathways have evolved to optimize antigen presentation to their respective T cells. A main focus of our laboratory is on efforts to understand molecular events in processing of antigen for presentation by MHC class II. The different stages of MHC class II-interactions with molecular chaperons involved in folding and traffic from the ER through the antigen-loading compartments, peptide exchange, and transport to the cell surface have been investigated. Through intense research on biophysical and biochemical properties of MHC class II molecules, we have learned that the conformational heterogeneity of MHC class II induced upon binding to different peptides is a key regulator in antigen presentation and epitope selection, and a determinant of the ability of MHC class II to participate in peptide association or dissociation and interaction with the peptide editor HLA-DM.

AB - T cells bearing αβ receptors recognize antigenic peptides bound to class I and class II glycoproteins encoded in the major histocompatibility complex (MHC). Cytotoxic and helper T cells respond respectively to peptide antigens derived from endogenous sources presented by MHC class I, and exogenous sources presented by MHC II, on antigen presenting cells. Differences in the MHC class I and class II structures and their maturation pathways have evolved to optimize antigen presentation to their respective T cells. A main focus of our laboratory is on efforts to understand molecular events in processing of antigen for presentation by MHC class II. The different stages of MHC class II-interactions with molecular chaperons involved in folding and traffic from the ER through the antigen-loading compartments, peptide exchange, and transport to the cell surface have been investigated. Through intense research on biophysical and biochemical properties of MHC class II molecules, we have learned that the conformational heterogeneity of MHC class II induced upon binding to different peptides is a key regulator in antigen presentation and epitope selection, and a determinant of the ability of MHC class II to participate in peptide association or dissociation and interaction with the peptide editor HLA-DM.

KW - Conformational heterogeneity

KW - H-bonds

KW - Immunodominance

KW - Kinetics

KW - MHC class II

KW - Peptide-receptive conformation

UR - http://www.scopus.com/inward/record.url?scp=77953960092&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953960092&partnerID=8YFLogxK

U2 - 10.1007/s12026-009-8138-1

DO - 10.1007/s12026-009-8138-1

M3 - Article

C2 - 20066513

AN - SCOPUS:77953960092

VL - 47

SP - 56

EP - 64

JO - Immunologic Research

JF - Immunologic Research

SN - 0257-277X

IS - 1-3

ER -